Details for Patent: 9,339,489
✉ Email this page to a colleague
Which drugs does patent 9,339,489 protect, and when does it expire?
Patent 9,339,489 protects SPRITAM and is included in one NDA.
This patent has twenty patent family members in nine countries.
Summary for Patent: 9,339,489
Title: | Rapid disperse dosage form containing levetiracetam |
Abstract: | A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 10 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to levetiracetam. |
Inventor(s): | Jacob; Jules (Yardley, PA), Coyle; Norman (Fort Washington, PA), West; Thomas G (Lawrenceville, NJ), Monkhouse; Donald C. (Radnor, PA), Surprenant; Henry L. (Phoenixville, PA), Jain; Nemichand B. (Princeton Junction, NJ) |
Assignee: | Aprecia Pharmaceuticals Company (Langhorne, PA) |
Application Number: | 14/277,901 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,339,489
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF ADMINISTERING LEVETIRACETAM | ⤷ Sign Up | |||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF ADMINISTERING LEVETIRACETAM | ⤷ Sign Up | |||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-002 | Jul 31, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF ADMINISTERING LEVETIRACETAM | ⤷ Sign Up | |||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-003 | Jul 31, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF ADMINISTERING LEVETIRACETAM | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,339,489
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014228990 | ⤷ Sign Up | |||
Australia | 2017202752 | ⤷ Sign Up | |||
Canada | 2906029 | ⤷ Sign Up | |||
China | 105188849 | ⤷ Sign Up | |||
China | 109908355 | ⤷ Sign Up | |||
European Patent Office | 2968994 | ⤷ Sign Up | |||
European Patent Office | 3431141 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |